Company: ANIX
Filing Date: 2025-02-06
Form Type: DEF 14A
Source: 0001493152-25-005199
Chunk: 1

Company: Anixa Biosciences Inc
Filing Date: 2025-02-06
Form: DEF 14A
Chunk 1
---
iling                                  
 Party:                                  |
| (4) | Date                                    
 Filed:                                  |

<div align='center'>ANIXA BIOSCIENCES, INC.

3150 Almaden Expressway, Suite 250

San Jose, CA 95118

February 6, 2025</div>

To the Stockholders of Anixa Biosciences, Inc.:

You are cordially invited to attend the 2025 Annual Meeting of Stockholders (the “ Virtual Meeting”) of Anixa Biosciences, Inc. (the “ Company”) to be held on a virtual basis on Thursday, March 20, 2025 at 10:00 a.m. Pacific Time, for the following purposes:

| 1. 
 2. 
 3. | To                                                                                                                               
 elect Dr. Amit Kumar, Dr. Arnold Baskies, Emily Gottschalk, and Lewis H. Titterton, Jr. as directors (the “Director Nominees”)   
 to serve on the Company’s Board of Directors (the “Board”) for a one-year term that expires at the 2026                          
 Annual Meeting of Stockholders, or until their successors are elected and qualified;                                             
 To                                                                                                                               
 approve on a non-binding, advisory basis the compensation of our named executive officers;                                       
 To                                                                                                                               
 ratify the appointment by the Board of Haskell & White LLP as the Company’s independent registered public accounting firm        
 for the fiscal year ending October 31, 2025;                                                                                     |
|:---|:---------------------------------------------------------------------------------------------------------------------------------|
| 4. | To                                                                                                                               
 select on a non-binding, advisory basis the frequency of conducting future stockholder advisory votes on named executive officer 
 compensation (which will be either every year, every two years or every three years); and                                        |
| 5. | To                                                                                                                               
 transact such other business as may properly come before the Virtual Meeting or any adjournment thereof.                         |

THE BOARD UNANIMOUSLY RECOMMENDS A VOTE FOR THE ELECTION OF EACH OF THE DIRECTOR NOMINEES, A vote FOR the approval on a non-binding, advisory basis, of the compensation of our named executive officers, A VOTE FOR THE RATIFICATION OF THE APPOINTMENT OF THE COMPANY’S INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM FOR THE FISCAL YEAR ENDING OCTOBER 31, 2025 and A VOTE FOR ONE YEAR FOR THE FREQUENCY OF CONDUCTING FUTURE STOCKHOLDER